Raymond W Cohen bought $289K of Kestra Medical Technologies (KMTS)
Executed Mar 7 2025, disclosed Sep 8 2025, 185 days later, against a two-business-day limit.
Over the 21 trading sessions from the disclosed entry session (Sep 8 2025), the stock returned +46.0% (delay-adjusted); from the execution session (Mar 7 2025), +5.8%. Derived: entry at the session's open, exit at the close 20 sessions later.
Raymond W Cohen (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Kestra Medical Technologies, Ltd. (KMTS). Across 1 priced purchase filing, the average 21-session return was +10.1% from execution and +10.8% from disclosure (delay-adjusted; derived). The largest single filing was $200K of KMTS (10,000 sh × $19.98, as filed), executed Mar 26.
Healthcare · Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→10,000 sh × $19.98
Exec Mar 26
Filed Mar 30 · 6:06 PM ET